Temporal variations in the hepatitis C virus intrahost population during chronic infection

Journal of Virology

Volumn 85, Issue 13, 2011, Pages 6369-6380

  Ramachandran, Sumathi ^a   Campo, David S ^a   Dimitrova, Zoya E ^a   Xia, Guo Liang ^a   Purdy, Michael A ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADAPTATION; ADULT; AGED; ARTICLE; CASE REPORT; CHRONIC DISEASE; COMMUNITY; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; HVR1 GENE; MALE; MOLECULAR EVOLUTION; NONHUMAN; NS5A GENE; POPULATION DISPERSION; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS MUTATION; BLOOD; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHYLOGENY; TIME; VIROLOGY;

HEPATITIS C VIRUS;

HVR1 PROTEIN, HEPATITIS C VIRUS; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

BLOOD; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

EID: 79960848222     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02204-10     Document Type: Article

References (57)

1. Abrahams, M. R., et al. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83, 3556-3567.
2. Alter, M. 2007. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 13, 2436-2441.
3. Alter, M. J., et al. 1992. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327, 1899-1905.
4. Bandelt, H., P. Forster, and A. Rohl. 1999. Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol. 16, 37-48.
5. Berry, A., J. Ajioka, and M. Kreitman. 1991. Lack of polymorphism on the Drosophila fourth chromosome resulting from selection. Genetics 129, 1111- 1117.
6. Billerbeck, E., T. Bottler, and R. Thimme. 2007. Regulatory T cells in viral hepatitis. World J. Gastroenterol. 13, 4858-4864.
7. Booth, J., U. Kumar, D. Webster, J. Monjardino, and H. C. Thomas. 1998. Comparison of the rate of sequence variation in the hypervariable region of E2/Ns1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27, 27223-27227.
8. Campo, D., Z. Dimitrova, R. Mitchell, J. Lara, and Y. Khudyakov. 2008. Coordinated evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 105, 9685-9690.
9. Charlesworth, D., B. Charlesworth, and M. Morgan. 1995. The pattern of neutral molecular variation under the background selection model. Genetics 141, 1619-1632.
10. Cox, A., et al. 2005. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42, 104- 112.
11. Davenport, F., A. Hennesy, and T. Francis. 1953. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med. 98, 641-656.
12. Duffy, M., et al. 2002. Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection. Virology 301, 354-364.
13. Excoffier, L., G. Laval, and S. Schneider. 2005. Arlequin (version 3.0), an integrated software package for population genetics data analysis. Evol. Bioinform. Online 1, 47-50.
14. Felsenstein, J. 1981. Evolutionary trees from DNA sequences, a maximum likelihood approach. J. Mol. Evol. 17, 368-376.
15. Figlerowicz, M., et al. 2010. Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Arch. Virol. 155, 1977-1987.
16. Finzi, D., S. Plaeger, and C. Dieffenbach. 2006. Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis. Clin. Vaccine Immunol. 13, 715-721.
17. Gerlach, J. T., et al. 2003. Acute hepatitis C, high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125, 80-88.
18. Girvan, M., and M. Newman. 2002. Community structure in social and biological networks. Proc. Natl. Acad. Sci. U. S. A. 99, 7821-7826.
19. Heathcote, J., and J. Main. 2005. Treatment of hepatitis C. J. Viral Hepat. 12, 223-235.
20. Jaeckel, E., et al. 2001. Treatment of acute hepatitis C with interferon alfa-2b. N. Engl. J. Med. 345, 1452-1457.
21. Kearney, M., et al. 2009. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J. Virol. 83, 2715-2727.
22. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105, 7552-7557.
23. Klenerman, P., and R. Zinkernagel. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394, 482-485.
24. Kosakovsky Pond, S. L., and S. D. Frost. 2005. Not so different after all, a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22, 1208-1222.
25. Kosakovsky Pond, S. L., S. D. W. Frost, and S. V. Muse. 2005. HyPhy, hypothesis testing using phylogenies. Bioinformatics 21, 676-679.
26. Kumar, U., J. Brown, J. Monjardino, and H. Thomas. 1993. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J. Infect. Dis. 167, 726-730.
27. López-Labrador, F., et al. 2007. Trends for genetic variation of hepatitis C virus quasispecies in human immunodeficiency virus 1-coinfected patients. Virus Res. 130, 285-291.
28. Macdonald, A., and M. Harris. 2004. Hepatitis C virus NS5A, tales of a promiscuous protein. J. Gen. Virol. 85, 2485-2502.
29. Meyer, K., M. Ait-Goughoulte, Z. Keck, S. Foung, and R. Ray. 2008. Antibody-dependent enhancement of hepatitis C virus infection. J. Virol. 82, 2140-2149.
30. Moir, S., and A. Fauci. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9, 235-245.
31. Morrison, D. A. 2010. Using data-display networks for exploratory data analysis in phylogenetic studies. Mol. Biol. Evol. 27, 1044-1057.
32. Nei, M., and W. Li. 1979. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc. Natl. Acad. Sci. U. S. A. 76, 5269-5273.
33. Neumann-Haefelin, C., et al. 2007. Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. J. Gen. Virol. 88, 1986-1991.
34. Nielsen, R., and Z. Yang. 2003. Estimating the distribution of selection coefficients from phylogenetic data with applications to mitochondrial and viral DNA. Mol. Biol. Evol. 20, 1231-1239.
35. Penin, F., J. Dubuisson, F. Rey, D. Moradpour, and J. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39, 5-19.
36. Posada, D., and K. Crandall. 1998. Modeltest, testing the model of DNA substitution. Bioinformatics 14, 817-818.
37. Posada, D., and K. A. Crandall. 2001. Intraspecific gene genealogies, trees grafting into networks. Trends Ecol. Evol. 16, 37-45.
38. Puro, V., et al. 1995. Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections. Am. J. Public Health 85, 1272-1275.
39. Qin, H., et al. 2005. HCV quasispecies evolution, association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/ HIV. Blood 105, 533-541.
40. Quer, J., et al. 2005. Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection. J. Virol. 79, 15131-15141.
41. Ramachandran, S., et al. 2008. End point limiting dilution real time PCR assay for evaluation of HCV quasispecies in serum. J. Virol. Methods 151, 217-224.
42. Ramírez, S., S. Pérez-Del-Pulgar, and X. Forns. 2008. Virology and pathogenesis of hepatitis C virus recurrence. Liver Transpl. 14, S27-S35.
43. Rehermann, B., and E. Shin. 2005. Private aspects of heterologous immunity. J. Exp. Med. 201, 667-670.
44. Rosa, D., et al. 2005. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. U. S. A. 102, 18544-18549.
45. Ross, R. S., et al. 2002. Risk of hepatitis C virus transmission from an infected gynecologist to patients, results of a 7-year retrospective investigation. Arch. Intern. Med. 162, 805-810.
46. Saitou, N., and M. Nei. 1987. The neighbor-joining method, a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406-425.
47. Reference deleted
48. Semmo, N., and P. Klenerman. 2007. CD4+ T cell responses in hepatitis C virus infection. World J. Gastroenterol. 13, 4831-4838.
49. Shankarappa, R., et al. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73, 10489-10502.
50. Shimizu, Y., et al. 1996. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223, 409-412.
51. Sullivan, D. G., et al. 2007. Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. J. Infect. Dis. 196, 239-248.
52. Templeton, A. 2008. The reality and importance of founder speciation in evolution. Bioessays 30, 470-479.
53. Turner, P., and L. Chao. 1999. Prisoner's dilemma in an RNA virus. Nature 398, 441-443.
54. von Hahn, T., et al. 2007. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132, 667-678.
55. Wölfl, M., et al. 2008. Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. J. Immunol. 181, 6435-6446.
56. Zhang, P., et al. 2007. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc. Natl. Acad. Sci. U. S. A. 104, 8449-8454.
57. Zhong, J., et al. 2006. Persistent hepatitis C virus infection in vitro, coevolution of virus and host. J. Virol. 80, 11082-11093.